His laboratory research focuses on the biology of immune inhibitory receptors including leukocyte Ig-like receptor subfamily B (LILRB) in cancer immunology and hematopoietic cells. He is also accustomed to working at the intersection of basic research and its clinical applications; anti-LILRB2 and anti-LILRB4 blocking antibodies discovered by his team/collaborators are in clinical trials for treatment of myeloid leukemia and solid cancers. He published 119 peer-reviewed publications in hematopoietic and cancer research fields. He was a recipient of several awards, including American Society of Hematology Junior Faculty Scholar Award, Leukemia & Lymphoma Society Scholar Award, and Royan International Research Award. He has trained 8 graduate students and 27 post-doctoral researchers. Many of his former postdoc trainees acquired faculty positions.